Do you know how caregiving works? It just happens. One day everything’s normal; the next thing you know, you’re in over your head dealing with stuff you never saw coming. I didn’t realise something was wrong until my uncle started getting confused about which medications he’d already taken. He got defensive when I asked about […]
The post Looking After Family: Making Home Work for Everyone appeared first on Medical News Bulletin.
A sharp zing from ice water can feel like a tiny alarm bell. Nothing is “wrong” exactly, but the mouth is sending a memo: teeth age, too. Oral health is now part of the same conversations as mobility and heart health, often covered in medical reporting. That attention matters because when the mouth feels off, […]
The post Aging and Your Smile: What Happens to Teeth Over Time appeared first on Medical News Bulletin.
An advisory board comprised of 14 physicians and health care experts will be part of Healio AI’s ongoing development, providing their guidance and clinical expertise, Healio announced today.
“The formation of the Healio AI Advisory Board reinforces our commitment to responsible, physician-informed AI that enhances clinical decision-making while maintaining the highest standards of trust, accuracy and transparency,” Joan-Marie Stiglich, ELS, Healio’s chief AI officer, said in a press release.
The Healio AI platform is designed to deliver evidence-based insights drawn from research, data and
Signs and symptoms of ocular surface disease could be significantly reduced within 4 days after treatment with shelf-stable cryopreserved amniotic membrane, according to a study published in Clinical Optometry.
The retrospective study explored the short- and long-term clinical outcomes of CAM360 AmnioGraft (BioTissue) for the treatment of dry eye disease and other ocular surface diseases. CAM360 AmnioGraft is intended to be more useful for patients with mild to moderate ocular surface disease than the company’s Prokera, which is often used in moderate to severe cases.
“The key differences
SMILE helped some patients with interocular astigmatic axis discordance achieve predictable correction, according to a study in Journal of Refractive Surgery.
Manrong Yu, MD, PhD, of Fudan University, Shanghai, and colleagues wrote that previous studies have revealed differing levels of success with SMILE based on type of astigmatism.
“By comparing the visual outcomes and vector analysis in both eyes of the same patient, this study seeks to provide insights into the predictability and efficacy of SMILE for various astigmatic conditions,” they wrote. “The findings may contribute to the
The Zika virus epidemic that began in Brazil in 2015 and quickly spread to other countries caused an unprecedented flood of neurological disease, especially among infants, and changed the perception of the mosquito-borne disease forever.
A virus once believed to be largely benign was suddenly ravaging the brains of infants and causing central nervous disease in adults, leading WHO to declare an international public health emergency in February 2016, which lasted 9 months.
Ten years later, many questions remain, including why the virus became so harmful and whether it will cause another
GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results presented at ASCO Gastrointestinal Cancers Symposium.
A retrospective analysis of more than 281,000 people showed those who used GLP-1s exhibited a 36% reduced risk for colorectal cancer compared with those who used aspirin. The benefit with GLP-1s appeared even greater among individuals at highest risk due to family history, genetic predisposition or other high-risk comorbidities, such as Crohn’s disease or ulcerative colitis.
“Aspirin has been the standard chemoprevention
Stopping weight loss medication led to weight regain and reversed improvements in cardiometabolic markers in under 2 years, according to a new systematic review and meta-analysis.
The data also suggest people gain weight faster after stopping medications vs. behavioral weight loss programs “regardless of how much weight was lost during treatment,” the researchers noted.
Weight loss medications are being increasingly integrated into obesity care, with WHO recently recommending the use of GLP-1 receptor agonists as a treatment for the chronic disease.
However, “real world
AI, augmented reality and virtual reality have been found to be useful tools in health care, with utilization in administrative tasks, diagnosis and drug discovery, among others.
However, these technologies can also be used preoperatively, intraoperatively and postoperatively to enhance patient care and improve efficiency in the OR. According to Safdar N. Khan, MD, AI can reduce preoperative time with planning automation.
“Especially in orthopedic surgery and spine surgery, preoperative planning is a huge part of what we do and trying to create the best operative plan using the data that
ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat immunoglobulin A nephropathy, address chronic kidney disease in specific populations and reduce comorbidity risks as well as innovations in dialysis.
“Yes, we can ... cure kidney diseases” was the title of the state-of-the-art lecture for the opening plenary session. During his presentation, Vlado Perkovic, MB, PS, PhD, scientia professor and provost at the University of New South Wales in Sydney, traced the goals of kidney care from slowing disease progression in the